About VRX World Pharmacy Private Limited
Data last updated:
VRX World Pharmacy Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2013PTC251597. Its GSTIN is 09AAECV4186H1ZY (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vipin Bansal and Anu Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 16 T/F Preet Vihar Vikas Marg, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹15,000. For the same year it recorded a net loss of ₹7,248 (net margin -48.3%) and EBITDA of -₹7,248 (EBITDA margin -48.3%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years.
The company is associated with 1 brand: Excel pharmaceuticals.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vxldrugs.com.
Company details
Contact details
VRX World Pharmacy Private Limited's registered office is in Delhi, Delhi. Its website is vxldrugs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressG – 16 T/F Preet Vihar Vikas Marg, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of VRX World Pharmacy Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
VRX World Pharmacy operates one associated brand: Excel pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures a range of traditional pharmaceutical products for healthcare needs. | vxldrugs.com |
Financials of VRX World Pharmacy Private Limited
FY 2025 filings availableVRX World Pharmacy Private Limited reported revenue of ₹15,000 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 13% over three years. EBITDA rose 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹7,248 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7,248 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -48.3% | ||||
| Net Profit Margin | -48.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of VRX World Pharmacy Private Limited, buy the company report.
Board of directors of VRX World Pharmacy Private Limited
VRX World Pharmacy has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vipin Bansal | Director | 03 May 2013 | 13 Years 5 Months | Current |
| Anu Bansal | Director | 03 May 2013 | 13 Years 5 Months | Current |
Peer comparison
VRX World Pharmacy Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vandana Laboratories Private Limited | ₹15,500 (FY 2024) | -100.0% | New Delhi, Delhi, India | |||
| Sakksa Pharma Private Limited | ₹15,400 (FY 2025) | Hyderabad, Telangana, India | ||||
| Humana Formulations Private Limited | ₹15,230 (FY 2018) | -90.0% | Vadodara, Gujarat, India | |||
| VRX World Pharmacy Private Limitedthis company | ₹15,000 (FY 2025) | -₹7,248 | -48.3% | Delhi, India | ||
| Jyostna Laboratories Private Limited | ₹15,000 (FY 2024) | 0.0% | Hyderabad, Telangana, India |
To see the full peer comparison of VRX World Pharmacy Private Limited, buy the company report.
Auditor
VRX World Pharmacy Private Limited is audited by Pawan Shubham & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Pawan Shubham & Co. | FY 2023 | 011573C |
Shareholding
The shareholding of VRX World Pharmacy Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of VRX World Pharmacy Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving VRX World Pharmacy Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for VRX World Pharmacy Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
VRX World Pharmacy has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECV4186H1ZY | Uttar Pradesh | Active | 09 Jun 2020 |
To see the full GST registrations and return filing status of VRX World Pharmacy Private Limited, buy the company report.
Recent activity
VRX World Pharmacy Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Anu Bansal was appointed as Director on 03 May 2013.
Frequently asked questions
VRX World Pharmacy is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 May 2013 (13+ years old) and is registered under CIN U85100DL2013PTC251597.
VRX World Pharmacy has 2 current directors:
- Vipin Bansal - Director
- Anu Bansal - Director
The latest financial statements of VRX World Pharmacy on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of VRX World Pharmacy is 09AAECV4186H1ZY, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of VRX World Pharmacy is U85100DL2013PTC251597. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
VRX World Pharmacy was incorporated on 03 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of VRX World Pharmacy by revenue are Vandana Laboratories Private Limited, Sakksa Pharma Private Limited, Humana Formulations Private Limited, Jyostna Laboratories Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anu Bansal was appointed as Director on 03 May 2013. Vipin Bansal was appointed as Director on 03 May 2013.
VRX World Pharmacy can be reached through the website vxldrugs.com. Its registered office is in Delhi, India.
The registered office of VRX World Pharmacy is at G – 16 TF Preet Vihar Vikas Marg, Delhi, India – 110092.
VRX World Pharmacy operates in the pharma industry, in the drug formulation and development segment.